FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1207 October 14, 1993 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: A new tool in our armamentarium against opportunistic infections in AIDS is always welcome, and the recent trial of atovaquone by Hughes et al. (May 27 issue)¹ demonstrates that this drug will have its place in that struggle. I am disturbed, however, by the months of glossy advertisements for atovaquone (one of which appears in the same issue) that contain a pair of chest radiographs presumably demonstrating the response of Pneumocystis carinii pneumonia to therapy with the drug. The nearly opaque lungs in the first radiograph are replaced by a gratifyingly black translucence in the post-therapy film. . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.